inclusion criteria: * diagnosis of ards (berlin criteria) * hospitalized with at least severe covid-19 (fda 2020) * receiving support for acute lung injury/respiratory distress via supplemental oxygen * serum aspartate aminotransferase (ast) concentration ≤ 120 u/l and serum alanine aminotransferase (alt) concentration ≤ 150 u/l * serum total bilirubin ≤ 1.8 mg/dl, in the absence of gilbert's syndrome or hemolysis

inclusion criteria: * diagnosis of ards (berlin criteria) * hospitalized with at least severe covid-19 (fda 2020) * receiving support for acute lung injury/respiratory distress via supplemental oxygen * serum aspartate aminotransferase (ast) concentration ≤ 120 u/l and serum alanine aminotransferase (alt) concentration ≤ 150 u/l * serum total bilirubin ≤ 1.8 mg/dl, in the absence of gilbert's syndrome or hemolysis

inclusion criteria: - diagnosis of ards (berlin criteria) - hospitalized with at least severe covid-19 (fda 2020) - receiving support for acute lung injury/respiratory distress via supplemental oxygen - serum aspartate aminotransferase (ast) concentration ≤ 120 u/l and serum alanine aminotransferase (alt) concentration ≤ 150 u/l - serum total bilirubin ≤ 1.8 mg/dl, in the absence of gilbert's syndrome or hemolysis

inclusion criteria: - diagnosis of ards (berlin criteria) - hospitalized with at least severe covid-19 (fda 2020) - receiving support for acute lung injury/respiratory distress via supplemental oxygen - serum aspartate aminotransferase (ast) concentration ≤ 120 u/l and serum alanine aminotransferase (alt) concentration ≤ 150 u/l - serum total bilirubin ≤ 1.8 mg/dl, in the absence of gilbert's syndrome or hemolysis